KLK3 and prostate cancer: Our findings contrast to some extent with those of the US Veterans Aging Cohort Study, which showed marginally lower prostate cancer rates in MWH than men without HIV when adjusting for potential confounders and PSA testing (incidence rate ratio 0.93; 95% CI, 0.86–1.01; ref. 6).